Patent US3923989A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3923989A Expired / Lapsed US ⏱️ 0.0 years remaining

Nitro substituted picolinonitriles as anti-bacterial and anti-fungal agents

Assignee: Sandoz AG
•
Filing: 1974-08-20
•
Granted: 1975-12-02
•
Expires: 1994-08-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Nitro substituted picolinonitriles, in particular 3-nitropicolinonitrile, have been found to be useful as anti-bacterial and anti-fungal agents.

Inventors

  • 👤 Paul L Anderson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:57
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/78; C07D213/84

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 33 words
A METHOD OF TREATING BACTERIA AND FUNGI, WHICH COMPRISES INTERNALLY OR TOPICALLY ADMINISTERING TO A MAMMMAL IN NEED OF SAID TREATMENT AN ANTI-BACTERIAL OR ANTI-FUNGAL EFFECTIVE AMOUNT OF A COMPOUND OF THE FORMULA:
Claim 2
Independent Claim 33 words
A METHOD OF TREATING BACTERIA AND FUNGI, WHICH COMPRISES INTERNALLY OR TOPICALLY ADMINISTERING TO A MAMMMAL IN NEED OF SAID TREATMENT AN ANTI-BACTERIAL OR ANTI-FUNGAL EFFECTIVE AMOUNT OF A COMPOUND OF THE FORMULA:
Claim 3
Dependent Claim 25 words
A method according to claim 1 wherein said compound is administered internally at a daily dose of from about 100 milligrams to about 6.0 grams.
Claim 4
Dependent Claim 34 words
A method according to claim 1 wherein the compound is administered in a unit dosage form comprising said compound to the extent of from about 25 milligrams to about 3000 grams per unit dosage.
Claim 5
Dependent Claim 24 words
A method according to claim 1 wherein said compound is administered internally at a daily dose of from about 250 milligrams to about2.5 grams.
Claim 6
Dependent Claim 34 words
A method according to claim 1 wherein the compound is administered in a unit dosage form comprising said compound to the extent of from about 62.5 milligrams to about 1.25 grams per unit dosage.
Claim 7
Dependent Claim 11 words
A method according to claim 1 wherein said compound is 3-nitro-picolinonitrile.
Claim 8
Dependent Claim 11 words
The method according to claim 1 wherein said compound is 4-nitro-picolinonitrile.
Claim 9
Dependent Claim 29 words
A method according to claim 1 wherein said compound is administered topically in an topical composition containing said compound in a concentration by weight of 0.5 to 30 percent.
Claim 10
Dependent Claim 23 words
A method according to claim 8 wherein the topical composition contains said compound in a concentration by weight of 0.5 to 10 percent.
Claim 11
Dependent Claim 11 words
The method according to claim 8 wherein said compound is 3-nitro-picolinonitrile.
Claim 12
Dependent Claim 11 words
The method according to claim 8 wherein said compound is 4-nitro-picolinonitrile.
Claim 13
Dependent Claim 28 words
A pharmaceutical composition in solid or sterile solution form useful in treating bacteria and fungus infections topically, comprising as the active ingredient thereof a compound of the formula:
Claim 14
Dependent Claim 28 words
A pharmaceutical composition in solid or sterile solution form useful in treating bacteria and fungus infections topically, comprising as the active ingredient thereof a compound of the formula:
Claim 15
Dependent Claim 22 words
A pharmaceutical composition according to claim 12 wherein said compound is present at a concentration by weight of 0.5 to 10 percent.
Claim 16
Dependent Claim 12 words
The pharmaceutical composition of claim 12 wherein the active ingredient is 3-nitro-picolinonitrile.
Claim 17
Dependent Claim 12 words
The pharmaceutical composition of claim 12 wherein the active ingredient is 4-nitro-picolinonitrile.
Claim 18
Dependent Claim 10 words
The pharmaceutical composition of claim 12 which is an ointment.
Claim 19
Dependent Claim 11 words
The pharmaceutical composition of claim 12 which is a topical cream.
Claim 20
Dependent Claim 28 words
A pharmaceutical composition in solid or sterile solution form useful in treating bacteria and fungus infections internally, comprising as the active ingredient thereof a compound of the formula:
Claim 21
Dependent Claim 28 words
A pharmaceutical composition in solid or sterile solution form useful in treating bacteria and fungus infections internally, comprising as the active ingredient thereof a compound of the formula:
Claim 22
Dependent Claim 30 words
A pharmaceutical composition according to claim 18 in which said compound is present in said composition in an amount by weight of from about 62.5 milligrams to about 1,250 milligrams.
Claim 23
Dependent Claim 13 words
The pharmaceutical composition according to claim 18 wherein the active ingredient is 3-nitro-picolinonitrile.
Claim 24
Dependent Claim 13 words
The pharmaceutical composition according to claim 18, wherein the active ingredient is 4-nitro-picolinonitrile.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-12-01 1979-06-02 1979-12-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-12-01 1983-06-02 1983-12-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-12-01 1987-06-02 1987-12-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag